Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study.

Ho, Cheng-Maw; Lee, Chih-Hsin; Lee, Ming-Chia; Zhang, Jun-Fu; Wang, Jann-Yuan; Hu, Rey-Heng; Lee, Po-Huang

Ho, Cheng-Maw; Lee, Chih-Hsin; Lee, Ming-Chia; Zhang, Jun-Fu; Wang, Jann-Yuan; Hu, Rey-Heng; Lee, Po-Huang.

Afiliación

Ho CM; Department of Surgery and Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Lee CH; College of Medicine, National Taiwan University, Taipei, Taiwan.
Lee MC; Division of Pulmonary Medicine, Wanfang Hospital, Taipei Medical University, Taipei, Taiwan.
Zhang JF; Department of Pharmacy, New Taipei City Hospital, New Taipei, Taiwan.
Wang JY; Department of Internal Medicine, National Taiwan University Hospital, #7 Chung-Shan South Road, Taipei, 10002, Taiwan.
Hu RH; College of Medicine, National Taiwan University, Taipei, Taiwan. jywang@ntu.edu.tw.
Lee PH; Department of Internal Medicine, National Taiwan University Hospital, #7 Chung-Shan South Road, Taipei, 10002, Taiwan. jywang@ntu.edu.tw.

BMC Cancer ; 18(1): 401, 2018 04 10.

Article en En | MEDLINE | ID: mdl-29631561

Asunto(s)

Antagonistas de Receptores de Angiotensina/uso terapéutico; Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico; Carcinoma Hepatocelular/prevención & control; Quimioprevención; Neoplasias Hepáticas/prevención & control; Anciano; Carcinoma Hepatocelular/etiología; Carcinoma Hepatocelular/mortalidad; Comorbilidad; Femenino; Estudios de Seguimiento; Hepatitis B/complicaciones; Hepatitis B/virología; Hepatitis C/complicaciones; Hepatitis C/virología; Humanos; Neoplasias Hepáticas/etiología; Neoplasias Hepáticas/mortalidad; Masculino; Persona de Mediana Edad; Modelos de Riesgos Proporcionales; Estudios Retrospectivos; Factores de Riesgo

Palabras clave

Angiotensin II receptor blockers; Angiotensin-converting enzyme inhibitors; Chemoprevention; Comparative effectiveness; Hepatocellular carcinoma; High-risk cohort

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de la Enzima Convertidora de Angiotensina / Carcinoma Hepatocelular / Quimioprevención / Antagonistas de Receptores de Angiotensina / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google